The purpose of this renewal application is to continue to study the role of the ras oncogenes in induced thymic lymphomas With the results obtained in the previous period of the grant we are going to analyze the pathological alterations associated with this family of oncogenes at the molecular level. To fulfil that goal we will investigate if ras is an early or late event in this system using different modifications of the polymerase chain reaction (PCR) technique. This should provide a clue to the question of whether ras acts in initiation or progression in the process of tumor development. To approach the problem from another angle we will use our transgenic mouse lines with the N-ras oncogene to assess the degree of contribution of activated ras genes to the tumorigenic process triggered by inducing agents. We will also analyze here our recent finding that transgenic lines with the normal N-ras protooncogene also present associated malignancies. As a complement we will make N-ras constructs with promoter-enchancers that should direct expression of the oncogene to the thymus to investigate if N-ras is tumorigenic when highly expressed in T cells since there is where we initially isolated that oncogene. To understand better how ras can contribute to the tumorigenic process it is necessary to address the regulation of expression and function of the ras genes. In the previous period of the grant we have isolated and characterized a cDNA for a gene closely adjacent to N-ras and we will analyze how this spatial relationship can modulate N-ras expression and we will study the possible functional interaction, of the two gene products. Finally, we will approach the study of ras function analyzing the role of ras genes in signal transduction using the PCI2 cell system where we have already reported that ras genes seem to be involved in NGF and bFGF signal transduction. In summary, this proposal analyzes at the molecular level the role of ras oncogenes in the pathological alterations to which they have been associated, specifically tumor development. To gain a better knowledge of these processes several aspects of the ras functional pathways will be also analyzed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA036327-11
Application #
2089084
Study Section
Pathology B Study Section (PTHB)
Project Start
1984-01-01
Project End
1996-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Lynch, Stephen J; Zavadil, Jiri; Pellicer, Angel (2014) In TCR-stimulated T-cells, N-ras regulates specific genes and signal transduction pathways. PLoS One 8:e63193
Benet, Marta; Dulman, Robin Yates; Suzme, Raffi et al. (2012) Wild type N-ras displays anti-malignant properties, in part by downregulating decorin. J Cell Physiol 227:2341-51
Osei-Sarfo, Kwame; de Castro, Ignacio Perez; Pellicer, Angel (2012) p15(INK4b) plays a crucial role in murine lymphoid development and tumorigenesis. Carcinogenesis 33:708-13
Osei-Sarfo, K; Martello, L; Ibrahim, S et al. (2011) The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral. Oncogene 30:3661-71
Perez de Castro, Ignacio; Benet, Marta; Jimenez, Maria et al. (2005) Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation. Cancer Res 65:3249-56
Diaz, Roberto; Lue, Jeffrey; Mathews, Jeremy et al. (2005) Inhibition of Ras oncogenic activity by Ras protooncogenes. Int J Cancer 113:241-8
Perez de Castro, Ignacio; Bivona, Trever G; Philips, Mark R et al. (2004) Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol 24:3485-96
Diaz, Roberto; Lopez-Barcons, Lluis; Ahn, Daniel et al. (2004) Complex effects of Ras proto-oncogenes in tumorigenesis. Carcinogenesis 25:535-9
Corral, Teresa; Jimenez, Maria; Hernandez-Munoz, Inmaculada et al. (2003) NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity. J Cell Physiol 197:214-24
Perez de Castro, Ignacio; Diaz, Roberto; Malumbres, Marcos et al. (2003) Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res 63:1615-22

Showing the most recent 10 out of 67 publications